Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -211.58% is 66% below its 5-year average of -127.49%, around the middle of its 5-year range (-463.49%–-39.24%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.53% below its 12-month average of -208.39%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -211.58%.
RETURN ON INVESTED CAPITAL (ROIC)
-211.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-208.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-194.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-127.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.53%
CURRENT VS 3Y AVG
-9.02%
CURRENT VS 5Y AVG
-65.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-493.58%
vs the sector median at left
Longeveron Inc.
Market Cap
$7.15M
Return on Invested Capital (ROIC)
-211.58%
TTM Avg
-208.39%
3Y Avg
-194.08%
5Y Avg
-127.49%
Market Cap
$7.12M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-166.69%
3Y Avg
-591.28%
5Y Avg
-439.14%
Market Cap
$7.19M
Return on Invested Capital (ROIC)
-219.15%
TTM Avg
-109.13%
3Y Avg
-72.14%
5Y Avg
-33.59%
Market Cap
$7.19M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-383.35%
3Y Avg
-220.46%
5Y Avg
-246.83%
Market Cap
$7.07M
Return on Invested Capital (ROIC)
-208.39%
TTM Avg
-54.78%
3Y Avg
-47.23%
5Y Avg
-47.23%
Market Cap
$7.04M
Return on Invested Capital (ROIC)
-232.05%
TTM Avg
-321.25%
3Y Avg
-211.94%
5Y Avg
-167.22%
Market Cap
$7.31M
Return on Invested Capital (ROIC)
-995.44%
TTM Avg
-481.38%
3Y Avg
-268.85%
5Y Avg
-219.77%
Market Cap
$6.88M
Return on Invested Capital (ROIC)
-101.07%
TTM Avg
-100.00%
3Y Avg
-93.40%
5Y Avg
-94.83%
Market Cap
$7.46M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-63.63%
3Y Avg
-49.78%
5Y Avg
-53.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Longeveron Inc. (LGVN) | $7.15M | -211.58% | -208.39% | -194.08% | -127.49% |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | N/A | -166.69% | -591.28% | -439.14% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.19M | -219.15% | -109.13% | -72.14% | -33.59% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.19M | N/A | -383.35% | -220.46% | -246.83% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | -208.39% | -54.78% | -47.23% | -47.23% |
| KALA BIO, Inc. (KALA)vs › | $7.04M | -232.05% | -321.25% | -211.94% | -167.22% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -995.44% | -481.38% | -268.85% | -219.77% |
| Exicure, Inc. (XCUR)vs › | $6.88M | -101.07% | -100.00% | -93.40% | -94.83% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.46M | -107.08% | -63.63% | -49.78% | -53.46% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | -90.17% | -79.44% | -64.42% | -71.54% |
ROIC
-211.6%
ROE
-225.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -211.58% |
| 2026-03-31 | -135.67% |
| 2025-12-31 | -341.00% |
| 2025-09-30 | -208.81% |
| 2025-06-30 | -144.88% |
| 2025-03-31 | -97.17% |
| 2024-12-31 | -71.90% |
| 2024-09-30 | -65.94% |
| 2024-06-30 | -112.41% |
| 2024-03-31 | -463.49% |
| 2023-12-31 | -256.80% |
| 2023-09-30 | -253.07% |
| 2023-06-30 | -160.30% |
| 2023-03-31 | -106.33% |
| 2022-12-31 | -80.03% |
| 2022-09-30 | -62.81% |
| 2022-06-30 | -52.20% |
| 2022-03-31 | -47.30% |
| 2021-12-31 | -43.58% |
| 2021-09-30 | -58.71% |
| 2021-06-30 | -39.24% |
| 2021-03-31 | -23.67% |
| 2020-12-31 | -67.66% |
| 2020-09-30 | -40.50% |
